Dendritic cells (DCs), which are known to support immune activation during infection, may also regulate immune homeostasis in resting animals. Here we show that mice lacking the ubiquitin-editing molecule A20 specifically in DCs spontaneously showed DC activation and population expansion of activated T cells. Analysis of DC-specific epistasis in compound mice lacking both A20 and the signaling adaptor MyD88 specifically in DCs showed that A20 restricted both MyD88-independent signals, which drive activation of DCs and T cells, and MyD88-dependent signals, which drive population expansion of T cells. In addition, mice lacking A20 specifically in DCs spontaneously developed lymphocyte-dependent colitis, seronegative ankylosing arthritis and enthesitis, conditions stereotypical of human inflammatory bowel disease (IBD). Our findings indicate that DCs need A20 to preserve immune quiescence and suggest that A20-dependent DC functions may underlie IBD and IBD-associated arthritides.
Immune homeostasis in resting animals has long been considered a consequence of the absence of infectious or inflammatory stimulation. However, published studies suggest that immunostimulatory ligands such as microbial molecules may be sensed in unperturbed animals [1] [2] [3] [4] . Such findings have raised many questions about which ligands are delivered to host cells under steady-state conditions, which cells of the immune system respond to such ligands and how such cells regulate their responses to the ligands.
Dendritic cells (DCs) are specialized sentinels that detect inflammation or microbial pathogens via various receptors, such as tumor necrosis factor (TNF) receptors and Toll-like receptors (TLRs) 5, 6 . During overt immunization or infection, such stimuli cause DCs to upregulate expression of major histocompatibility complex (MHC) molecules, T cell-costimulatory molecules and cytokines and thereby recruit and activate other cells of the immune response 5, 7, 8 . As TLR ligands are expressed by commensal microbes and host nucleic acids can trigger inflammatory pathways 9, 10 , it is possible that host cells such as DCs may also encounter activating ligands in steady-state conditions. In this context, the nature, duration and/or intensity of signals in DCs may determine whether and how DCs stimulate cells of the innate and adaptive immune responses 6, 11, 12 . Thus, intracellular proteins that regulate these signaling pathways could have critical roles in controlling DC activation and immune homeostasis in steady-state conditions. A20 is a potent anti-inflammatory protein that uses deubiquitinating, E3 ligase and ubiquitin-binding functions to regulate activation of the transcription factor NF-κB 13, 14 . Genetic and biochemical studies indicate that A20 restricts activation signals from TNF, TLRs, nucleotide-binding oligomerization domain (Nod) proteins and the costimulatory molecule CD40 by editing ubiquitin chains on key signaling proteins that transduce these signals [14] [15] [16] [17] [18] . A20-deficient mice spontaneously develop severe inflammatory disease and die perinatally, which indicates that A20 preserves immune homeostasis 14, 19 . In addition, single-nucleotide polymorphisms (SNPs) in the locus encoding human A20 (TNFAIP3; called 'A20' here) have been associated with several human autoimmune diseases, including systemic lupus erythematosus 20, 21 , rheumatoid arthritis 22, 23 , psoriasis 24, 25 and celiac disease 26 , which suggests that altered A20-dependent functions contribute to human autoimmunity. Given the critical roles of A20 in restricting diverse activating signals and the potential roles of such signals in DC function, we hypothesized that A20 expression in DCs may be important for immune homeostasis. To investigate the roles of A20 in regulating DC functions, we have generated mice that lack A20 expression specifically in DCs.
RESULTS

A20 prevents spontaneous DC activation
To determine the relative expression of A20 in DCs in steadystate conditions, we analyzed mRNA in conventional DCs (cDCs: CD11c hi Ly6C − and positive for MHC class II) and plasmacytoid DCs (pDCs: CD11c lo CD11b − Ly6C + B220 + ) purified from spleens of wild-type mice. Although cDCs and pDCs had markedly disparate expression of interleukin 1β (IL-1β) mRNA, both cDCs and pDCs had similar expression of A20 mRNA (Fig. 1a) . To determine whether A20 regulates DC functionality, we generated mice with loxP-flanked alleles of the gene encoding mouse A20 (Tnfaip3; called 'A20' here) and bred those mice to mice with transgenic expression of Cre recombinase under control of the Cd11c promoter (A20 fl/fl Cd11c-Cre mice 18, 27 ; Supplementary Fig. 1a ). Deletion of exon 2 of A20 occurred at high efficiency in cDCs (and slightly lower efficiency in pDCs) in A20 fl/fl Cd11c-Cre mice (Supplementary Fig. 1b-e) . In contrast to mice globally deficient in A20 (A20 −/− mice) 19 , A20 fl/fl Cd11c-Cre mice were grossly healthy until at least 6 months of age (data not shown). Thus, A20 deficiency in DCs does not cause the cachexia and perinatal death of A20 −/− mice.
The two main DC populations in the spleen (cDCs and pDCs) were readily detectable in A20 fl/fl Cd11c-Cre mice (Fig. 1b) , which indicated that A20 was not required for DC development. In the steady state, DCs have modest expression of MHC class II and T cell-costimulatory molecules. Activation of DCs triggers the upregulation of these at the cell surface. To determine whether A20 restricts DC activation, we analyzed cell-surface expression of those activation markers on DCs from A20 fl/fl Cd11c-Cre mice. Expression of the costimulatory molecules CD80 and CD40 (but not CD86) was higher on A20 fl/fl Cd11c-Cre cDCs than on control A20 +/+ Cd11c-Cre cDCs ( Fig. 1c,d) , which indicated that A20-deficient DCs were spontaneously activated in vivo. Similarly, whereas pDCs from control mice had uniformly low expression of MHC class II, approximately 50% of A20 fl/fl Cd11c-Cre pDCs had higher expression of this activation marker (Fig. 1e) . The expression of CD80, CD86 and CD40 was more than threefold higher on A20-deficient pDCs than on wild-type pDCs ( Fig. 1f,g) . Thus, A20 expression in DCs prevented their spontaneous activation in vivo.
A20 prevents DC-triggered splenomegaly and lymphadenopathy
During overt immunization or infection, expression of costimulatory molecules and cytokines by DCs drives the recruitment and activation of cells of the immune response. To determine whether A20 expression in DCs maintains immune homeostasis, we examined lymphoid organs from A20 fl/fl Cd11c-Cre and control A20 +/+ Cd11c-Cre mice. Despite seeming outwardly healthy, A20 fl/fl Cd11c-Cre mice developed considerable splenomegaly and lymphadenopathy within 3 weeks of birth ( Supplementary Fig. 2 ) and accumulated large numbers of CD11b + inflammatory myeloid cells, including F4/80 + CD169 − monocytes ( Fig. 2a-d and data not shown). These cells constituted nearly 50% of nonerythroid splenocytes and over 5% of lymph node cells ( Fig. 2a,c) . Lymph nodes from A20 fl/fl Cd11c-Cre mice contained tenfold more inflammatory CD11b + F4/80 + cells and fivefold more B cells and T cells, including CD4 + CD25 + Foxp3 + regulatory T cells, than did those from control A20 +/+ Cd11c-Cre mice (Fig. 2d) . These findings indicated that A20 expression in DCs prevented population expansion of both myeloid and lymphoid cells at steady state.
Loss of DCs results in the population expansion of myeloid cells 28, 29 . We thus sought to determine whether the population expansion of myeloid cells observed in A20 fl/fl Cd11c-Cre mice represented a loss or gain of DC function. We generated radiation chimera by reconstituting wild-type mice with roughly equal proportions of A20 fl/fl Cd11c-Cre and wild-type hematopoietic cells. In such mice, the potential loss of immunosuppressive function by A20-deficient DCs would be compensated for by the wild-type DCs. At 4 weeks after reconstitution, spleens of hematopoietic chimeras were over fourfold larger than and contained more activated monocytes than those of mice reconstituted with control A20 +/+ Cd11c-Cre hematopoietic cells ( Fig. 2e,f) . These results suggested that A20-deficient DCs induced splenomegaly and population expansion of myeloid cells in a physiologically dominant way over wild-type DCs. 
A r t i c l e s
To begin to determine how A20-deficient DCs cause population expansion of myeloid cells, we first stimulated A20 −/− or A20 +/+ bone marrow-derived DCs (BMDCs) with lipopolysaccharide (LPS). After stimulation with LPS, A20 −/− DCs produced threefold more IL-6 and tenfold more TNF and IL-12 than did control DCs (Fig. 2g) . Thus, A20 directly restricted the response of DCs to LPS. Production of IL-10 and type I interferons were also enhanced in A20 −/− DCs ( Fig. 2g and Supplementary Fig. 3 ), which indicated that loss of A20 did not preclude expression of these cytokines. To assess the ability of A20 −/− DCs to acutely recruit myeloid cells in vivo, we labeled LPSactivated DCs with the cytosolic dye CFSE, injected them into the footpads of wild-type mice and then quantified both DCs (CFSE + ) that had migrated to the draining lymph nodes and monocytes (CFSE − CD11b + F4/80 + ) recruited to those lymph nodes after 24 h. Although we obtained similar numbers of A20 −/− DCs and A20 +/+ control DCs from draining lymph nodes (<0.025% of all cells; data not shown), more monocytes were recruited to lymph nodes in recipients of A20 −/− DCs than in mice that received control DCs (Fig. 2h) . Therefore, activated A20 −/− DCs induce more myeloid inflammation than do wild-type DCs.
To determine whether A20 −/− DCs drive myeloid inflammation by producing proinflammatory cytokines, we assessed the involvement of TNF and IL-6 in this acute process. After adoptive transfer of LPS-activated A20 −/− DCs into the footpads of wild-type mice, antibody-mediated blockade of either IL-6 or TNF partially inhibited the recruitment of myeloid cells into draining lymph nodes ( Fig. 2i) .
Combined with the observation that A20 fl/fl Cd11c-Cre mice had 25-fold higher serum concentrations of IL-6 ( Fig. 2j) , these experiments suggested that A20 suppressed DC production of inflammatory cytokines, thereby preserving myeloid-cell homeostasis.
A20 expression in DCs preserves T cell homeostasis
The development, homeostasis and activation of T lymphocytes depend on DC functions. Intrathymic T cell development, including that of CD4 + CD25 + Foxp3 + regulatory T cells, was normal in A20 fl/fl Cd11c-Cre mice ( Fig. 3a,b ). In the periphery, regulatory T cell populations (frequency of total CD4 + T cells) and their expression of the transcription factor Foxp3 were normal in A20 fl/fl Cd11c-Cre mice and there were more regulatory T cells, similar to the population expansion of conventional CD4 + or CD8 + T cells (Figs. 2d and 3b and data not shown). Thus, DCs do not need A20 to support the development and maintenance of regulatory T cells. In contrast, peripheral homeostasis of conventional T cells was grossly disrupted in A20 fl/fl Cd11c-Cre mice. Nearly 50% of splenic T cells in A20 fl/fl Cd11c-Cre mice expressed the early activation marker CD69, compared with only 10% in control A20 +/+ Cd11c-Cre mice ( Fig. 3c,d) . Additionally, the frequency and number of activated CD44 hi CD62L lo CD4 + or CD8 + T cells were greater in A20 fl/fl Cd11c-Cre mice ( Fig. 3e,f) . These results indicated that A20 expression in DCs prevented the spontaneous activation of T cells. In addition, although heterozygous A20 +/fl Cd11c-Cre mice did not show splenomegaly or population expansion of myeloid cells, these mice consistently had over twofold more activated T cells than did A20 +/+ Cd11c-Cre control mice (Fig. 2a,c and Supplementary Figs. 2 and 3e,f) . Thus, haploinsufficient expression of A20 in DCs compromised their ability to preserve T cell quiescence. Spontaneous DC activation, T cell activation and T cell population expansion occurred by 3 weeks of age in A20 fl/fl Cd11c-Cre mice. Those findings suggested that A20-deficient DCs potently induced the activation and proliferation of naive T cells. Consistent with that hypothesis, A20 −/− DCs drove aberrant T cell activation in a physiologically dominant way relative to wild-type DCs in mixed hematopoietic chimeras ( Supplementary Fig. 4 ). Ovalbumin peptide-pulsed A20 −/− BMDCs induced more population expansion of OT-II CD4 + T cells than did wild-type BMDCs after adoptive transfer into normal mice (Supplemental Fig. 5a ). In addition, A20 +/fl Cd11c-Cre mice mounted greater T cell responses than did A20 +/+ Cd11c-Cre mice after immunization with ovalbumin ( Supplementary Fig. 5b ). To further determine how A20-deficient DCs disrupt T cell homeostasis, we adoptively transferred CFSE-labeled, naive, wild-type CD8 + T cells into A20 fl/fl Cd11c-Cre and control A20 +/+ Cd11c-Cre mice. These polyclonal T cells developed normally in wild-type mice, and thus their homeostasis in recipient A20 fl/fl Cd11c-Cre mice depended entirely on regulatory controls in peripheral lymphoid organs. At 10 d after adoptive transfer, over 95% of transferred T cells remained naive in control A20 +/+ Cd11c-Cre mice (Fig. 3g) . In contrast, within 3 d, a substantial proportion of transferred CD8 + T cells had converted into CD44 hi CD62L lo activated T cells in A20 fl/fl Cd11c-Cre mice, and nearly all transferred cells were activated by 10 d after transfer. In addition, within those 10 d, transferred CD8 + T cells underwent multiple cellular divisions in A20 fl/fl Cd11c-Cre mice, whereas no substantial proliferation occurred in control A20 +/+ Cd11c-Cre mice (Fig. 3h) . We obtained similar results with OT-I CD8 + T cells (which have transgenic expression of an ovalbumin-specific T cell antigen receptor; Supplementary Fig. 6a ). These observations indicated that A20-deficient DCs delivered potent signals that induced aberrant activation and proliferation of naive CD8 + T cells even in the absence of overt immunization. At steady state, DCs can support antigen-specific T cell tolerance in peripheral lymphoid organs 11, [30] [31] [32] . To determine whether aberrant T cell activation driven by A20-deficient DCs compromised induction of peripheral tolerance, we adoptively transferred OT-II CD4 + T cells into 5-week old A20 fl/fl Cd11c-Cre mice and control A20 +/+ Cd11c-Cre mice and then administered a tolerizing dose of cognate ovalbumin-derived peptide 12, 33 . At 10 d after injection of peptide, the population of OT-II T cells in A20 +/+ Cd11c-Cre recipients was 10% that of mock-treated A20 +/+ Cd11c-Cre mice ( Fig. 3i) , consistent with tolerization via T cell deletion. In contrast, injection of cognate peptide into A20 fl/fl Cd11c-Cre mice induced 300% population expansion of OT-II T cells. Thus, injection of tolerizing soluble peptide resulted in 30-fold more OT-II T cells in A20 fl/fl Cd11c-Cre mice than in control A20 +/+ Cd11c-Cre mice (Fig. 3i) . Thus, A20 fl/fl Cd11c-Cre mice not only failed to induce peripheral deletion of OT-II CD4 + T cells but also induced substantial antigen-specific population expansion of these T cells under tolerizing conditions. These results indicated that A20 expression in DCs prevented promiscuous T cell activation, aberrant proliferation and disruption of peripheral T cell tolerance.
A20 inhibits adaptor MyD88-independent signals in DCs
The DC activation in A20 fl/fl Cd11c-Cre mice in the absence of overt stimulation suggested that A20 restricts intracellular signaling cascades in DCs that are triggered by commensal and/or endogenous ligands in steady-state conditions. The nature of such signals and how they regulate steady-state DC functions are unknown. As A20-deficient DCs were hyper-responsive to TLR ligands, we interrogated the role of signals from the adaptor MyD88 in DCs by interbreeding A20 fl/fl Cd11c-Cre mice to mice with loxPflanked Myd88 alleles (Myd88 fl/fl mice) 34 . The resulting compound A20 fl/fl Myd88 fl/fl Cd11c-Cre mice lacked both A20 and MyD88 specifically in DCs. We then used these mice to determine which A20-restricted signals in DCs were MyD88 dependent and which were MyD88 independent.
To determine the nature of steady-state signals regulated by A20, we first analyzed the expression of activation markers on DCs from A20 fl/fl Myd88 fl/fl Cd11c-Cre and control Myd88 fl/fl Cd11c-Cre mice. Similar to DCs from A20 fl/fl Cd11c-Cre mice, DCs from A20 fl/fl Myd88 fl/fl Cd11c-Cre mice spontaneously had high expression of CD80 and CD40 (Fig. 4a) . Thus, MyD88 signals were not needed to trigger spontaneous activation of A20-deficient DCs in vivo. We obtained similar results with A20 fl/fl Cd11c-Cre mice globally deficient in MyD88 (A20 fl/fl Cd11c-CreMyd88 −/− mice; Fig. 4b) , which confirmed that the steady-state stimuli that triggered DC activation in A20 fl/fl Cd11c-Cre mice did not require MyD88 signaling in DCs or any other cell type. Thus, in resting mice, A20 restricted MyD88independent signals in DCs to prevent spontaneous DC activation.
To determine the consequences of those dysregulated MyD88independent signals on T cell homeostasis, we analyzed lymph node T cells from A20 fl/fl Myd88 fl/fl Cd11c-Cre and control Myd88 fl/fl Cd11c-Cre or A20 fl/fl Cd11c-Cre mice. The frequency of activated CD44 hi CD62L lo CD4 + or CD8 + T cells was four-to fivefold higher in A20 fl/fl Myd88 fl/fl Cd11c-Cre mice than in control Myd88 fl/fl Cd11c-Cre mice (Fig. 4c) . Moreover, the frequency of activated T cells in A20 fl/fl Myd88 fl/fl Cd11c-Cre mice was similar to that of A20 fl/fl Cd11c-Cre mice, which indicated that MyD88independent signals that triggered DC activation also drove aberrant activation of T cells.
The findings reported above suggested that high expression of costimulatory molecules on A20-deficient DCs inappropriately stimulated T cells and disrupted T cell homeostasis. To test that idea, we adoptively transferred polyclonal, naive wild-type CD8 + T cells into A20 fl/fl Cd11c-Cre mice and administered nondepleting blocking antibody to CD80 (anti-CD80) and anti-CD86 for 9 d. Although the majority of transferred T cells (69%) became CD44 hi CD62L lo in A20 fl/fl Cd11c-Cre recipients of isotype-matched control antibodies, blockade of CD80 and CD86 resulted in a lower frequency of activated T cells in A20 fl/fl Cd11c-Cre mice, of 23% ( Fig. 4d,e ). On average, blockade of costimulatory molecules in A20 fl/fl Cd11c-Cre mice inhibited the aberrant activation of adoptively transferred CD8 + T cells by more than 60% (Fig. 4f) . Aberrant proliferation of adoptively transferred CD8 + T cells in A20 fl/fl Cd11c-Cre mice was also antagonized by blockade of CD80 and CD86 ( Fig. 4g-i ). Together these findings indicated that A20 restricted MyD88-independent signals in DCs that triggered spontaneous DC activation, upregulation of costimulatory molecules and aberrant T cell activation.
A20 inhibits MyD88-dependent signals in DCs
Comparison of A20 fl/fl Myd88 fl/fl Cd11c-Cre mice and A20 fl/fl Cd11c-Cre mice also allowed us to determine the role of MyD88-dependent signals in DCs that control immune homeostasis. Total cellularity and lymphocyte numbers were largely normal in A20 fl/fl Myd88 fl/fl Cd11c-Cre mice, in contrast to the gross lymphadenopathy of A20 fl/fl Cd11c-Cre mice (Fig. 5a) . This finding indicated that hyper-responsiveness of A20-deficient DCs to steady-state MyD88 signals drove the aberrant lymphocyte population expansion of A20 fl/fl Cd11c-Cre mice.
To determine how unrestricted MyD88 signaling in DCs perturb T cell homeostasis, we measured the cytokines produced by A20 −/− , A20 −/− Myd88 −/− and various control DCs in response to LPS. Although A20 −/− DCs produced much more TNF and IL-6 than did wild-type DCs, A20 −/− Myd88 −/− DCs produced only 10% that of A20 −/− DCs (Fig. 5b) . Hence, A20 inhibited the production of these MyD88-dependent cytokines in DCs. To determine whether these DC products supported T cell population expansion in A20 fl/fl Cd11c-Cre mice, we adoptively transferred wild-type CD8 + T cells into A20 fl/fl Cd11c-Cre mice and administered blocking anti-IL-6 or anti-TNF. Blockade of either IL-6 or TNF resulted in approximately 50% less CD8 + T cell proliferation (Fig. 5c) , which indicated that overexpression of these cytokines in A20 fl/fl Cd11c-Cre mice induced T cell population expansion. Antibody-mediated blockade also inhibited T cell activation, which suggested that IL-6 and TNF additionally contributed to aberrant DC-driven T cell activation. Thus, A20 restricted MyD88-dependent signals in DCs to limit production of cytokines that drove aberrant T cell population expansion.
A20-dependent DC functions prevent colitis
Given the genetic association of SNPs in A20 with autoimmune disease in humans, we analyzed A20 fl/fl Cd11c-Cre mice for the development of such conditions. We did not detect more serum immunoglobulin, DNA-specific antibodies or immunoglobulin deposits in kidneys of A20 fl/fl Cd11c-Cre mice (data not shown). However, by 5 months of age, 100% of A20 fl/fl Cd11c-Cre mice developed an inflammatory bowel disease (IBD) in which colons were enlarged in diameter, contained foci of expanded cellular populations in the lamina propria and were depleted of goblet cells (Fig. 6a,b) . These mice also had more splenic interferon-γ-producing CD4 + T cells (Fig. 6c) . Although A20 fl/ fl Cd11c-Cre mice 2-3 months of age did not show overt colitis, these younger mice had much higher titers of serum immunoglobulin A (IgA), a pathology consistent with perturbed bowel homeostasis 35, 36 (Fig. 6d) . Moreover, these precolitic A20 fl/fl Cd11c-Cre mice were more susceptible to dextran sodium sulfate (DSS)-induced colitis. DSS-treated A20 fl/fl Cd11c-Cre mice suffered exaggerated weight loss, and disease severity required premature termination of the experiment, whereas control Cd11c-Cre mice showed only moderate weight loss and diarrhea (Fig. 6e) . Together these results indicated that DCs needed A20 to maintain intestinal immune homeostasis and prevent epithelial damage-triggered colitis.
Misregulated activation of either myeloid or lymphoid cells can compromise bowel homeostasis 37, 38 . To determine whether the spontaneous colitis of A20 fl/fl Cd11c-Cre mice required lymphocytes or was mediated solely by activated myeloid cells, we interbred A20 fl/fl Cd11c-Cre mice with lymphocyte-deficient mice lacking recombination-activating gene 1 (Rag1 −/− mice). Although large numbers of myeloid cells accumulated in the spleen, histological analysis of colons from compound A20 fl/fl Cd11c-CreRag1 −/− mice indicated that bowel inflammation did not occur (Fig. 6f,g) . Thus, the spontaneous colitis of A20 fl/fl Cd11c-Cre mice involved DC-induced disruption of lymphocyte homeostasis.
The absence of colitis in A20 fl/fl Cd11c-Cre Rag1 −/− mice suggested that A20-deficient DCs stimulated excessive T cell activation in the intestines of A20 fl/fl Cd11c-Cre mice to cause IBD. To directly assess this pathophysiological mechanism, we adoptively transferred naive A r t i c l e s wild-type CD4 + T cells into A20 fl/fl Cd11c-CreRag1 −/− mice and control Cd11c-CreRag1 −/− mice and monitored the development of colitis in these mice. T cell-complemented A20 fl/fl Cd11c-CreRag1 −/− mice rapidly lost weight and developed diarrhea within 2 weeks of T cell transfer. We terminated the experiment within 4 weeks after transfer because of the disease severity in A20 fl/fl Cd11c-CreRag1 −/− mice. (Fig. 7a) . During the same time period, T cell-complemented A20 +/fl Cd11c-CreRag1 −/− and A20 +/+ Cd11c-CreRag1 −/− mice lost only modest amounts of weight. Grossly, the spleens of A20 fl/fl Cd11c-Cre Rag1 −/− mice were more enlarged and their colons were shorter and thicker than those of control mice ( Fig. 7b  and Supplementary Fig. 7a ). Histological analysis confirmed that the colonic lamina propria of A20 fl/fl Cd11c-CreRag1 −/− mice was infiltrated with large numbers of inflammatory cells ( Supplementary  Fig. 7b,c) . Together these results indicated that A20-deficient DCs induced rapid activation and proliferation of T cells that led to T cell-mediated colitis in A20 fl/fl Cd11c-Cre mice.
Association of A20 SNPs with human Crohn's disease SNPs in the human A20 locus have been associated with several autoimmune diseases, including systemic lupus erythematosus (SLE) 20,21 and rheumatoid arthritis 22, 23 . Because A20 fl/fl Cd11c-Cre mice did not manifest overt autoimmunity but had perturbed intestinal homeostasis, we investigated whether SNPs in human A20 are associated with human Crohn's disease, an IBD. We analyzed a whole-genome scan of patients with Crohn's disease and healthy controls from the Wellcome Trust Case-Control Consortium 39 . Of 443 genotyped or imputed SNPs from the A20 locus, we identified 28 SNPs (P < 0.01), 11 of which were highly significant for association with Crohn's disease (P < 1 × 10 −5 ; Supplementary  Fig. 8) . We confirmed association with the SNP rs7753394 (ref. 39 ; P = 3.9 × 10 −6 ) and identified three previously unknown SNPs of even higher significance (P < 2 × 10 −6 ) among patients with Crohn's disease. The SNP with the highest significance was the imputed SNP rs2683064, with a P value of 1.8 × 10 −6 and an odds ratio of 1.25 (95% confidence interval, 1.14-1.36). Furthermore, conditional analysis of each locus to the top SNP indicated that the multiple signals in this region were due to linkage disequilibrium with a single Crohn's disease-associated locus. These associations suggested that in addition to regulating susceptibility to other autoimmune diseases, A20 regulates susceptibility to human IBD. Together with the susceptibility of A20 fl/fl Cd11c-Cre mice to colitis, these results reinforced the idea that A20 functions in DCs are critical in preventing inflammatory responses and preserving intestinal homeostasis. A20 fl/fl Cd11c-Cre mice develop IBD-associated arthritis Colitis in human patients is frequently associated with a subset of seronegative arthritic diseases. We thus assessed the development of arthritis in A20 fl/fl Cd11c-Cre mice. Notably, approximately 10% of A20 fl/fl Cd11c-Cre mice spontaneously developed gross limb joint inflammation within 4-6 months of age (Supplementary Fig. 9 ). Histopathological analysis showed considerable synovitis and inflammatory infiltrates surrounding the tendon and entheses in arthritic A20 fl/fl Cd11c-Cre mice (Fig. 8a-f) . Acute arthritis and macroscopic joint swelling resolved within weeks of disease onset (data not shown), but histopathology of joints from 1-year-old mice showed ankylosis, bone cysts and abnormal formation of bone and cartilage at joint surfaces ( Fig. 8g-j) . Thus, after the onset of arthritis, chronic inflammation of the joint and bone probably persisted throughout the lifetime of the afflicted mice. During the acute and chronic phases of arthritic disease, we consistently observed enthesitis at tendon insertion sites of the tibial-talar joints (Fig. 8d,g-j) . That finding was particularly notable, as enthesitis is a hallmark of spondyloarthropathies, a heterogeneous group of seronegative rheumatic diseases that occur in a subset of human patients with IBD. To immunophenotype the spontaneous arthritis observed in A20 fl/fl Cd11c-Cre mice, we tested serum from arthritic mice (acute and chronic) for the presence of autoantibodies related to arthritic disease. All animals had negligible serum titers of rheumatoid factor, antinuclear antibodies and antibodies to cyclic citrullinated peptide, the best-characterized immunoglobulin determinants of rheumatoid arthritis (Fig. 8k) . Thus, A20 fl/fl Cd11c-Cre mice spontaneously developed chronic, seronegative, ankylosing arthritis with enthesitis.
In human patients with IBD, such pathologies often include spondyloarthritis involving the axial skeleton 40 . To determine whether the arthritis of A20 fl/fl Cd11c-Cre mice extended beyond the peripheral joints, we analyzed micro-computed tomography scans of A20 fl/fl Cd11c-Cre and control mice. These analyses confirmed the presence of bone erosions throughout the limb joints and vertebrae of A20 fl/fl Cd11c-Cre mice (Supplementary Fig. 10) .
Thus, A20 fl/fl Cd11c-Cre mice spontaneously developed seronegative arthritis, enthesitis and spondyloarthritis that resembled stereotypic IBD-associated arthritis.
DISCUSSION
DCs, well recognized for their abilities to activate immune responses, are emerging as critical regulators of immune homeostasis. Loss of DCs has been shown to lead to the population expansion of myeloid cells, a phenotype ascribed to a greater abundance of the ligand for the receptor tyrosine kinase Flt3 (refs. 28, 29) . Prolonged survival of DCs leads to gradual autoimmunity, perhaps due to DC-mediated stimulation of T cells for inappropriate periods of time 41, 42 . The inability of DCs to respond to tolerizing IL-10 or β-catenin signals or to expand regulatory T cell populations also perturbs intestinal immune homeostasis 35, 43, 44 . Distinct from those mechanisms, we have now shown that multiple signaling pathways in DCs must be tightly restricted by A20 to maintain homeostasis of both myeloid and lymphoid cells. The profound splenomegaly and lymphadenopathy that occurred in A20 fl/fl Cd11c-Cre mice within 2-3 weeks of birth contrasts with the more subtle phenotypes of many of the strains noted above. Thus, restriction of intracellular signaling cascades triggered by steady-state stimuli may be particularly critical to the maintenance of immune homeostasis by DCs. A20 restricts the duration and/or magnitude of overt signaling by TLR, CD40 and Nod proteins by limiting NF-κB signaling [16] [17] [18] [19] . Such functions probably contribute to the ability of A20 to restrict the immunogenicity of DC-based vaccines, which make use of 45, 46 . By investigating A20 function in DCs during the steady state, we have shown that A20 was also needed to restrict the more subtle signals sensed by DCs under resting conditions. As A20 may set a signaling threshold for TNF-induced NF-κB to prevent unwanted inflammatory responses 47 , A20 may serve a similar function for TLR and other signals to prevent DC activation in response to naturally occurring stimuli in vivo.
The nature and origin of steady-state signals sensed by DCs and how DCs use such signals to regulate immune homeostasis is key to understanding how DC functions may prevent or contribute to disease. To delineate the physiological signals sensed by DCs, we combined A20 fl/fl and Myd88 fl/fl alleles with the Cd11c-Cre transgene. This analysis of DC-specific epistasis showed that A20 restricted both MyD88-dependent and MyD88-independent signals in DCs under resting conditions. MyD88-dependent signals might include signals triggered by TLR, IL-1, IL-18 or IL-33. MyD88-independent signals may include TLR signals dependent on the adaptor TRIF (TICAM1), other microbial sensors (such as Nod-like receptors and helicase RIG-1-like receptors), nucleic acid sensors (such as sensors of RNA or DNA) or other proinflammatory proteins (such as the TNF receptor family) 14, [16] [17] [18] [19] . As our results indicated that multiple intracellular signaling pathways were triggered in DCs, DCs may engage multiple ligands during steady-state conditions.
Our studies have also identified the immunological consequences of the lack of A20 regulation of MyD88-dependent and MyD88-independent signaling cascades in DCs. A20 restricted MyD88-independent signals that upregulated expression of T cellcostimulatory molecules on DCs and drove aberrant activation of naive T cells. In addition to limiting MyD88-independent signals in DCs, A20 restricted MyD88-dependent signals that drove the secretion of IL-6 and TNF, T cell population expansion and lymphadenopathy. Hence, a model of DC-regulated T cell homeostasis has emerged in which steady-state stimuli such as commensal TLR ligands trigger both MyD88-independent and MyD88-dependent intracellular signaling cascades in DCs that are normally restricted by A20. In the absence of A20, unrestrained MyD88-independent signals result in higher expression of co-stimulatory molecules and cause spontaneous T cell activation, and unrestrained MyD88-dependent signals result in more DC secretion of cytokines such as IL-6 that drive the population expansion of T cells and myeloid cells. Future studies with other loxP-flanked alleles of molecules that regulate intracellular signaling cascades should further clarify the nature of steady-state signals that regulate DC functions in resting mice.
In contrast to several other strains of mice with perturbed DCs, A20 fl/fl Cd11c-Cre mice did not develop autoantibodies 41, 42, 48 . That result was somewhat unexpected, as A20-deficient DCs were hyper-responsive to MyD88 signals, and several reports have attributed signaling by TLRs and MyD88 to the development of spontaneous autoimmunity 9, 10, 49 . Moreover, the lymphadenopathy of A20 fl/fl Cd11c-Cre mice involved the population expansion of both T cells and B cells, yet except for IgA, serum immunoglobulins were unperturbed. One potential explanation for the absence of autoantibodies in A20 fl/fl Cd11c-Cre mice might have been myeloid cell-mediated inhibition or cytolysis of activated B cells. In contrast, mice that lack A20 specifically in B cells (A20 fl/fl Cd19-Cre mice) have more germinal center B cells and spontaneously develop autoantibodies and lupus-like disease 18 . Thus, A20 preserves immune homeostasis and prevents autoimmune disease via several cell type-specific functions.
Our studies have reinforced the proposal that A20 is an enzyme whose expression is closely tied to the ability to maintain immune quiescence.
Hypomorphic expression of A20 in B cells in A20 +/fl Cd19-Cre mice perturbs B cell homeostasis and causes autoantibody production 18 . Similarly, A20 +/fl Cd11c-Cre mice had more spontaneously activated T cells, and the proliferation of naive CD4 + T cells in A20 +/fl Cd11c-CreRag1 −/− mice was intermediate between that of A20 +/+ Cd11c-CreRag1 −/− mice and A20 fl/fl Cd11c-CreRag1 −/− mice. As our genetic studies have strengthened the association of noncoding SNPs in A20 with susceptibility to human Crohn's disease, and as noncoding SNPs in A20 (and one coding SNP) have also been linked to susceptibility to rheumatoid arthritis, systemic lupus erythematosus, psoriasis and celiac sprue, and as at least one SNP resulted in lower expression of A20 mRNA, lower expression of A20 may well explain how noncoding A20 SNPs predispose humans to inflammatory and autoimmune diseases [20] [21] [22] [23] [24] [25] [26] 50 .
Our findings that A20-dependent DC functions preserved intestinal homeostasis in A20 fl/fl Cd11c-Cre mice provide mechanistic insight into how A20 deficiency may cause susceptibility to IBD and IBD-associated arthritides. Even in a tolerogenic setting, A20deficient DCs potently induced T cell population expansion and drove T cell-mediated colitis despite elaborating large amounts of IL-10. Hence, in addition to secreting tolerogenic proteins, DCs must restrict their expression of inflammatory proteins to maintain intestinal homeostasis. The spontaneous development of seronegative arthritis, spondyloarthritis and enthesitis in A20 fl/fl Cd11c-Cre mice has provided further insights into the pathophysiology of these conditions, particularly as these conditions develop in combination with colitis. IBD-associated arthritis is a member of the family of spondyloarthopathies in humans, a heterogenous group of arthritic diseases strongly associated with HLA-B27 (~90% prevalence) 51 . Like A20 fl/fl Cd11c-Cre mice, HLA-B27-transgenic rats and mice that overexpress TNF (TNF ∆ARE mice) also develop enthesopathy accompanied by intestinal inflammation 36, 52 . A20-deficient DCs produced more TNF after activation, and it is plausible that A20 fl/fl Cd11c-Cre mice and TNF ∆ARE mice have partially overlapping pathophysiologies. The responsiveness of human patients with spondyloarthritis to therapy with anti-TNF further suggests that TNF-driven pathology is intimately linked to human disease 51, 53 . Higher serum concentrations of IgA and IL-6 in A20 fl/fl Cd11c-Cre mice are also associated with human spondyloarthopathies 53, 54 , and gene-expression profiling of peripheral blood mononuclear cells suggests that patients with spondyloarthritis may have deficient A20 expression 55, 56 . The rare combination of spontaneously occurring colitis, seronegative arthritis and enthesitis in mice lacking A20 in DCs suggests that disruption of A20dependent DC functions may underlie colitis and colitis-associated arthritides in human patients. Therapies directed at DCs and A20 may be particularly useful for such diseases.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/. 
